A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Improving Surgical Decision-making in Young Women With Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Gut Decontamination In Pediatric Allogeneic Hematopoietic
- Status
- COMPLETED
- Phase
- PHASE2
Novel Social Media Intervention For Older Br CA Patients
- Status
- COMPLETED
- Phase
- NA
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing
- Status
- COMPLETED
- Phase
- PHASE2
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Status
- RECRUITING
- Phase
- PHASE3
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
OLAParib COmbinations
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Lenalidomide for Adult Histiocyte Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
- Status
- COMPLETED
- Phase
- N/A
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2